Market Cap

Neuren Pharmaceuticals Limited Market Capitalization:

A$2.60 Billion

AUD as of July 1, 2024

US$1.73 Billion

business Neuren Pharmaceuticals Limited Company Profile

Neuren Pharmaceuticals Limited Main Stock Listing

ASX: NEU

Market Capitalization History of Neuren Pharmaceuticals Limited

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $309.91 B
Vertex Pharmaceuticals Incorporated $117.36 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $59.14 B
Marinomed Biotech AG $58.56 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of Neuren Pharmaceuticals Limited market cap

Date Market Cap YoY Change
Jan. 1, 2024 A$3.13 B 171.15%
Jan. 1, 2023 A$1.15 B 159.88%
Jan. 1, 2022 A$443.6 M 151.09%
Jan. 31, 2021 A$176.7 M 0.00%
Jan. 1, 2021 A$176.7 M -24.73%
Jan. 31, 2020 A$234.7 M -35.69%
Jan. 1, 2020 A$365.0 M 148.25%
Jan. 31, 2019 A$147.0 M -9.52%
Jan. 1, 2019 A$162.5 M -63.69%
Jan. 31, 2018 A$447.5 M 11.94%
Jan. 1, 2018 A$399.8 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Neuren Pharmaceuticals Limited Categories

Australia languages Healthcare languages Biotechnology
Australia Healthcare Australia Biotechnology

Stocks & Indices

Neuren Pharmaceuticals Limited has the following listings and related stock indices.


Stock: ASX: NEU

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.